NASDAQ:ARHS

Arhaus, Inc. (NASDAQ: ARHS) Navigates Q1 2026 Earnings Amidst Record Revenue and Margin Pressures

Font: Financial Modeling Prep  • May 07, 2026

Market Chart
  • Arhaus achieved its highest first-quarter net revenue in company history, reaching $314.28 million, surpassing analyst estimates.
  • Despite record revenue, net income declined by 54.5% to $2 million, and gross margin decreased by 1.0%, indicating increased operational costs.
  • The company's earnings per share (EPS) of $0.02 met expectations but represented a year-over-year decrease from $0.03.

Arhaus, Inc. (NASDAQ: ARHS) is a leading lifestyle brand and premium retailer in the home furnishings market. The company operates a vertically integrated model, meaning it controls many stages of its supply chain. Arhaus focuses on expanding its physical showrooms and investing in technology to reach its customers and improve long-term revenue growth.

On May 7, 2026, Arhaus announced its first-quarter financial results. The company reported an earnings per share (EPS) of $0.02, which was in line with what financial analysts expected. This figure, however, represents a decrease from the $0.03 per share reported in the same quarter of the previous year.

The company also posted quarterly revenue of $314.28 million, which slightly beat the consensus estimate of $313.97 million. This marks a 0.9% increase from the prior year and represents the highest first-quarter net revenue in the company's history. Over the last four quarters, Arhaus has consistently surpassed revenue estimates.

Despite the record revenue, other financial metrics showed a decline. Gross margin, the profit made on goods sold, decreased by 1.0% to $114 million. Net income, or the company's total profit after all expenses, fell by 54.5% to $2 million for the quarter. This indicates higher costs relative to its sales.

From a valuation standpoint, Arhaus trades at a Price-to-Earnings (P/E) ratio of 15.42. This ratio helps investors gauge if a stock is over or undervalued compared to its earnings. The company's Debt-to-Equity ratio of 1.61 shows how much debt it uses to finance its assets relative to the value of shareholders' equity.

Market Overview
ENSC
Ensysce Biosciences, Inc.
$0.52
44.83%
SURG
SurgePays, Inc.
$0.33
45.48%
CELZ
Creative Medical Technology Holdings, Inc.
$1.15
71.95%
SPCX
Space Exploration Technologies Corp.
$114.92
6.14%
GAUZ
Gauzy Ltd. Ordinary Shares
$0.43
69.53%
ONFO
Onfolio Holdings, Inc.
$0.06
-17.36%
HTZ
Hertz Global Holdings, Inc.
$2.02
29.49%
NVDA
NVIDIA Corporation
$218.99
-0.10%
UWMC
UWM Holdings Corporation
$1.20
-34.78%
SOUN
SoundHound AI, Inc.
$7.08
10.11%